HARVARD BIOSCIENCE, INC. Impairment of Intangible Assets (Excluding Goodwill)
HARVARD BIOSCIENCE, INC. (HBIO) reported Impairment of Intangible Assets (Excluding Goodwill) of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2026-03-31 was $0.00.
- HARVARD BIOSCIENCE, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2025-03-31 was $0.00.
- HARVARD BIOSCIENCE, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2019-09-30 was $500.00K.
- HARVARD BIOSCIENCE, INC. impairment of intangible assets (excluding goodwill) for fiscal 2020 was $0.00.
- HARVARD BIOSCIENCE, INC. impairment of intangible assets (excluding goodwill) for fiscal 2018 was $0.00.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-08-11 | |
| 2020-12-31 | $0.00 10-K/A · filed 2021-03-17 | |
| 2019-09-30 | $500.00K 10-K · filed 2020-03-16 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |